Novel Agent Set for Unique Clinical Test in IBC

http://www.sciencedaily.com/releases/2013/12/131210163533.htm

Novel Agent Set for Unique Clinical Test in Inflammatory Breast Cancer

A drug now used to treat a type of lymphoma has shown surprising benefit in preclinical studies of inflammatory breast cancer, according to a researcher at Thomas Jefferson University's Kimmel Cancer Center.

Categories